Status:
COMPLETED
Evaluation of Celsior® in Liver Transplant Preservation.
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Sangstat Medical Corporation
Conditions:
Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The aim of the study is to determine the efficacy and safety of a preservation solution in liver transplantation. Its efficacy will be compared to the efficacy of other currently used preservation sol...
Detailed Description
The quality of organ preservation is a major determinant of initial graft function and survival. Graft viability is based on hypothermia, the organ being stored in a cold preservation solution. Celsi...
Eligibility Criteria
Inclusion
- Adult
- Primary liver transplantation
- Whole organ transplantation
- Agreement for a 1 year follow-up
- Informed written consent
Exclusion
- Liver disease secondary to clotting abnormalities
- Uncontrolled bacterial or viral disease at the time of transplantation
- Combined transplantations
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00151593
Start Date
February 1 2002
End Date
March 1 2006
Last Update
November 26 2007
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Digestive - Hôpital de la Côte de Nacre
Caen, France, 14033
2
Service de Chirurgie Digestive - Hôpital Henri Mondor
Créteil, France, 94010
3
Service de Chirurgie Viscérale et Transplantations - Hôpital Dupuytren
Limoges, France, 87042
4
Chirurgie générale et digestive - Hôpital de la Croix Rousse
Lyon, France, 69317